- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
COVID-19 Control in the United States: The Case for MaskingIn the control of COVID-19, the future perfect of the vaccine should not be the enemy of the present good, which is masking.
Latest:
Behavior-Based Diabetes Management: Impact on Care, Hospitalizations, and CostsThe Diabetes Care Rewards program offers a business case for health plans to promote engagement through use of contingent incentives, thus improving health outcomes and lowering costs.
Latest:
An Accelerated Hospital Observation Pathway to Reduce Length of Stay for Patients With COVID-19For select patients hospitalized due to COVID-19, an academic urban hospital implemented an observation pathway that incorporated mobile health technology, reducing hospital length of stay by more than 2 days.
Latest:
Price Transparency and Patient Engagement: Social Messaging MattersThis study examined the impact of price transparency and prosocial messaging on patient engagement of price-protected consumers in seeking value-based care.
Latest:
Contributor: The Future of Prior Authorization Under the Improving Seniors’ Timely Access to Care ActStreamlining the prior authorization process can improve care accuracy and patient access to care, writes Siva Namasivayam, CEO of Cohere Health.
Latest:
Insurance-Related Differences in Chronic Conditions Data Warehouse Comorbidities of Medicare BeneficiariesChronic Conditions Data Warehouse comorbidity data vary by insurance status. Analyses using these data that fail to account for insurance status are subject to information bias.
Latest:
Focus Turns to Unmet Needs in ITP, Related Autoimmune Diseases After Rilzabrutinib Approval: David Kuter, MD, DPhilThe most pressing questions in ITP involve finding a cure and developing treatments safe for use during pregnancy.
Latest:
The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial InsuranceInfliximab biosimilars created price competition causing insurance claims costs for infliximab originator and infliximab biosimilars to decrease, generating significant savings to the health care system.
Latest:
Preventive Care: Vaccines MatterA database of information about more than 30,000 patients verified improved morbidity and mortality due to vaccines and preventive health care in prospective trials.
Latest:
Cost-effectiveness of a 3-Year Tele-Messaging Intervention for Positive Airway Pressure UseLong-term tele-messaging was more effective than no messaging and short-term messaging for positive airway pressure use, and it was highly likely to be cost-effective with an acceptable willingness-to-pay threshold.
Latest:
Understanding Insurance Coverage Policies for Incretin Mimetics for Weight ManagementThe high cost of incretin mimetics for weight management limits insurance coverage and potentiates variation in utilization management strategies to control near-term spending.
Latest:
Emerging Data Suggest Select Benefit for Venetoclax in MDS: Ivo Carre, PhDIvo Carre, PhD, shares subgroup data that points to potential benefit in younger patients with high-risk MDS.
Latest:
Budget Impact Analysis of Biosimilar Natalizumab in the USProjected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab.
Latest:
Value-Based Care Through Postacute Home Health Under CMS PACT RegulationsAmong a patient population defined by CMS postacute care transfer regulations, home health vs no postacute care was associated with reduced 30-day readmissions and costs.
Latest:
Clinical Profile of COVID-19 Infection in Postvaccination IndividualsThis article describes the findings of an observational study carried out in India to examine the clinical profile of individuals detected to be COVID-19 positive post vaccination.
Latest:
Association Between Use of Clinician Performance Information and Patient ExperienceHigh patient experience scores were associated with the collection and use of any clinician performance information, especially with whether the practice shared this information internally to compare.
Latest:
Continuity of Opioid Prescribing Among Older Adults on Long-term OpioidsAmong older adults with chronic noncancer pain on long-term opioid therapy, greater continuity of opioid prescribing was significantly associated with fewer opioid-related adverse outcomes.
Latest:
Rising Use of Surveillance Colonoscopy and Potential ImpactsThe proportion of colonoscopies performed for postpolypectomy surveillance has increased significantly, particularly among older patients with limited life expectancy, raising concern for possible overuse.
Latest:
Industry-Informed Perspectives on the Benefits of Rideshare-Based Medical TransportationPrevious research on rideshare-based nonemergency medical transportation has limited generalizability due to the specific model studied, and the lack of trip-level data raises concerns of ecological fallacy.
Latest:
Evaluating Satisfaction With Pharmacist-Provided MTM Services in a Medicaid PopulationMedication therapy management (MTM) services were performed with a cohort of Medicaid patients, and their satisfaction with the program was assessed as part of a quality improvement initiative.
Latest:
Factors Associated With Lung Cancer Risk Factor DocumentationThis cross-sectional observational study found several factors associated with whether a patient had sufficient lung cancer risk factor documentation in the electronic health record.
Latest:
Increased Payments to Medicare Advantage Plans for Dually Eligible BeneficiariesIncreasing Medicare Advantage payments for full Medicaid enrollees was not associated with meaningful changes in inpatient or nursing home use.
Latest:
Closing PerspectivesExperts discuss how to evaluate the cost-effectiveness of continuous glucose monitoring (CGM) compared to traditional monitoring, considering both clinical and quality outcomes, and what combination of economic and quality data would most effectively support broader CGM adoption across health systems and payer organizations.
Latest:
Hospital Participation in Medicare ACOs: No Change in Admission Practices and SpendingHospital accountable care organization (ACO) participation did not impact emergency department admission rates, length of stay, or costs, suggesting limited effectiveness in reducing spending for unplanned admissions and challenging hospital-led ACO cost-saving strategies.
Latest:
Consumer-Centric Approach to Enhance Access to Pediatric Specialty CareThe authors’ organization optimized scheduling techniques that improved patient access to pediatric specialists to within 7 calendar days for new patients.
Latest:
An Assessment of Nurse Practitioner Low-Value Care Use in Primary CarePrimary care nurse practitioners were found to use low-value care at lower or relatively similar rates compared with the general clinician population.
Latest:
Final Thoughts on the Future of AML CarePanelists discuss how AML treatment has entered an exciting era of personalized medicine with increasing oral options and targeted therapies, while identifying immunotherapy as a major unmet need and expressing optimism about patients achieving long-term survival on current regimens.
Latest:
Factors Associated With Lung Cancer Risk Factor DocumentationThis cross-sectional observational study found several factors associated with whether a patient had sufficient lung cancer risk factor documentation in the electronic health record.
Latest:
Primary Care Nurse Practitioner Management of Adolescent Behavioral HealthPersonnel costs ($90,514) of a primary care–embedded adolescent behavioral health nurse practitioner over 2 years were 63% of the potential revenue generated ($144,449).
